-
Podophyllotoxin Derivative 5p and Drug Resistance
2026-09-02
The reference study shows that podophyllotoxin derivative 5p combines topoisomerase IIα catalytic inhibition with suppression of microtubule polymerization, creating a dual mechanism against drug-resistant cancer models. Its effects were linked to G2/M arrest, altered drug-efflux transporter expression, apoptosis, pyroptosis-associated signaling, and reduced resistant xenograft growth.
-
Scalable iMSC-EV Production for Pulmonary Fibrosis
2026-09-01
Gong et al. developed a bioreactor-based platform that generates extracellular vesicles from extended pluripotent stem cell-derived mesenchymal stem cells at clinically relevant scale. The resulting iMSC-EVs matched key characteristics of primary MSC-EVs and reduced fibrosis-associated injury in a bleomycin mouse model, supporting a more standardized route toward therapeutic EV manufacturing.
-
DiR as an Orthogonal Readout for Nanomedicine
2026-09-01
DiR (DiIC 18 (7)) is more than a membrane-labeling dye: it can provide an orthogonal view of cellular and tissue trafficking in complex nanomedicine studies. This article explains how to use its near-infrared persistence to interpret trypsin-responsive pancreatitis research without confusing membrane localization with therapeutic cargo release.
-
Pregnenolone Carbonitrile: PXR Research Guide
2026-08-31
Pregnenolone Carbonitrile, also called Pregnenolone-16α-carbonitrile, is a rodent pregnane X receptor agonist used to investigate xenobiotic metabolism, cytochrome P450 CYP3A induction, and cholestatic liver injury. Product specifications and a recent mouse study support its use as a mechanistic research tool, while species selectivity, formulation limits, and disease-model boundaries remain important.
-
Nilotinib (AMN-107): Kinase Assay Workflow
2026-08-31
Build reproducible phospho-signaling and viability workflows with Nilotinib (AMN-107) across BCR-ABL, KIT, and PDGFR-driven models. This guide combines practical compound handling with a careful, hypothesis-generating framework inspired by new findings on ribotoxic stress and UV-induced cell death.
-
BV6: Rewiring IAP Dependence for Translation
2026-08-30
BV6 is a Smac mimetic and IAP antagonist that helps translational researchers connect inhibitor-of-apoptosis biology with apoptosis induction, radiosensitization, chemotherapy response, immune-cell cytotoxicity, and endometriosis modeling. This thought-leadership perspective places the compound within a disciplined framework that separates mechanistic signal from disease-level outcome.
-
Moxidectin in Antifungal Synergy Assays
2026-08-29
Moxidectin extends beyond parasitic worm control as a practical potentiator candidate for amphotericin B and nystatin assays. This guide translates the Candida albicans findings into stock-preparation, checkerboard, biofilm, mechanism-validation, and troubleshooting workflows while keeping veterinary evidence separate from early antifungal research.
-
WIP1–p38 MAPK Control of Pyroptosis in Septic AKI
2026-08-28
The reference study identifies WIP1/PPM1D as a negative regulator of p38 MAPK-driven pyroptosis in sepsis-associated acute kidney injury. By combining single-cell sequencing, human tissue observations, LPS-induced mouse injury, HK2-cell experiments, and pharmacological inhibition, it links WIP1 activity to renal tubular inflammatory damage and provides a framework for testing this pathway mechanistically.
-
Cy5 Goat Anti-Rabbit IgG (H+L) Antibody Guide
2026-08-28
The Cy5 Goat Anti-Rabbit IgG (H+L) Antibody is a Cy5 conjugated secondary antibody for detecting rabbit primary antibodies in fluorescence-based assays. K1212 supports immunofluorescence, immunohistochemistry, immunocytochemistry, western blotting, and flow cytometry when the workflow is optimized for species compatibility, signal, background, and fluorescence preservation.
-
Haloprogin: Applied Antifungal Workflows
2026-08-27
Haloprogin combines strong dermatophyte activity with reported effects against Candida and selected Gram-positive bacteria, making it useful for layered antimicrobial screening. This guide translates published MIC/MFC methods and topical infection-model data into practical workflows, formulation choices, and troubleshooting strategies.
-
YC-1 and HIF-1α: From Hypoxia to Neural Injury
2026-08-27
Explore how YC-1, also known as 5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol, connects HIF-1α biology with soluble guanylyl cyclase signaling. This article translates a recent postoperative cognitive dysfunction study into practical assay and interpretation strategies for cancer research and neural injury models.
-
H 89 2HCl in Trigeminal Pain Signaling
2026-08-26
Explore how H 89 2HCl can help separate PKA activity from upstream cAMP changes in trigeminal pain research. This article translates recent CGRP/SP–Piezo2 findings into a practical, limitation-aware assay strategy.
-
Mono-ADP-Ribosylation Marks PARP7 for Degradation
2026-08-26
The reference study establishes that mono-ADP-ribosylation can function as an endogenous protein-degradation signal rather than only as a regulatory modification. By blocking ubiquitin-dependent turnover, the authors identify DTX2 as an E3 ligase that removes PARP7 and AHR during AHR pathway activation, revealing a feedback mechanism that limits AHR-driven transcription.
-
GSK343 and the Translational Logic of EZH2 Inhibition
2026-08-25
GSK343 is a selective, cell-permeable EZH2 inhibitor for dissecting H3K27me3 biology in cancer models. This thought-leadership article connects its mechanistic strengths and practical limitations with emerging evidence that polycomb-linked repression can influence tumor immunogenicity, while defining a disciplined path from chromatin assays to translational hypotheses.
-
Methicillin Sodium Salt in Reliable Cell Assays
2026-08-25
Learn how Methicillin sodium salt (SKU C3238) can support controlled Staphylococcus aureus infection research and improve interpretation of cell viability, proliferation, and cytotoxicity assays. This scenario-based guide connects mechanism, susceptibility ranges, formulation, controls, and vendor-selection decisions to practical laboratory workflows.